Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's Disease

20256 citationsJournal Articlehybrid Open Access

Authors

LDp/CDp monotherapy treatment may be suitable for up to 96 weeks.

Responsible consumption and production

Published in: Movement Disorders Clinical Practice

Volume 13, Issue 1, pp. 181-190

Field-Weighted Citation Impact: 8.26